Behavioral and immunological effects of exogenous butyrylcholinesterase in rhesus monkeys

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 3, 1999, Pages 523-530

  Matzke, Sarah Monique ^a   Oubre, John L ^a   Caranto, German R ^a   Gentry, Mary Kay ^a   Galbicka, Gregory ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Accuracy; Butyrylcholinesterase; Immunology; Latency; Memory; Operant behavior; Rhesus monkeys; Serial probe recognition (SPR)

Indexed keywords

CHOLINESTERASE; ORGANOPHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; IMMUNE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; ANTIBODY FORMATION; BEHAVIOR, ANIMAL; BUTYRYLCHOLINESTERASE; COGNITION; COLOR PERCEPTION; CONDITIONING, OPERANT; DISCRIMINATION LEARNING; HALF-LIFE; HORSES; HUMANS; MACACA MULATTA; MALE;

EID: 0033015982     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00183-X     Document Type: Article

References (24)

1. Ashani Y., Shapira S., Levy D., Wolfe A.D., Doctor B.P., Raveh L. Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochem. Pharmacol. 41:1991;37-41.
2. Brandeis R., Raveh L., Grunwald J., Cohen E., Ashani Y. Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats. Pharmacol. Biochem. Behav. 46:1993;889-896.
3. Broomfield C.A., Maxwell D.M., Solana R.P., Castro C.A., Finger A.V., Lenz D.E. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J. Pharmacol. Exp. Ther. 259:1991;633-638.
4. Castro C.A., Finger A. The use of serial probe recognition in non-human primates as a method for detecting cognitive deficits following CNS challenge. Neurotoxicology. 12:1991;125-127.
5. Castro C.A., Gresham V.C., Finger A.V., Maxwell D.M., Solana R.P., Lenz D.E., Broomfield C.A. Behavioral decrements persist in rhesus monkeys trained on a serial probe recognition task despite protection against soman lethality by butyrylcholinesterase. Neurotoxicol. Teratol. 16:1994;145-148.
6. Castro C.A., Larsen T., Finger A.V., Solana R.P., McMaster S.B. Behavioral efficacy of diazepam against nerve agent exposure in rhesus monkeys. Pharmacol. Biochem. Behav. 41:1991;159-164.
7. Doctor B.P., Raveh L., Wolfe A.D., Maxwell D.M., Ashani Y. Enzymes as pretreatment drugs for organophosphate toxicity. Neurosci. Biobehav. Rev. 15:1991;123-128.
8. Ellman G.L., Courtney K.D., Andres V. Jr., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;89-95.
9. Genovese R.F., Doctor B.P. Behavioral and pharmacological assessment of butyrylcholinesterase in rats. Pharmacol. Biochem. Behav. 51:1995;647-654.
10. Gentry M.K., Nuwayser E.S., Doctor B.P. Immunological effect of repeated adminsistration of cholinesterase in rabbits. Proc. Med. Defense Biosci. Rev. 1:1996;183-189.
11. Keeler J.R., Hurst C.G., Dunn M.A. Pyridostigmine used as a nerve agent pretreatment under wartime conditions. JAMA. 266:1991;693-695.
12. Leadbeater L., Inns R.H., Rylands J.M. Treatment of poisoning by soman. Fundam. Appl. Toxicol. 5:1985;S225-S231.
13. Matzke S.M., Castro C.A. Primacy and recency effects in rhesus monkeys (Macaca mulatta) using a serial probe recognition task III. A developmental analysis. Dev. Psychobiol. 32:1998;215-224.
14. Maxwell D.M., Brecht K.M., Doctor B.P., Wolfe A.D. Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase. J. Pharmacol. Exp. Ther. 264:1993;1085-1089.
15. Maxwell D.M., Castro C.A., De La Hoz D.M., Gentry M.K., Gold M.B., Solana R.P., Wolfe A.D., Doctor B.P. Protection of rhesus monkeys against soman and prevention of performance decrement by pretreatment with acetylcholinesterase. Toxicol. App. Pharmacol. 115:1992;44-49.
16. Maxwell D.M., Wolfe A.D., Ashani Y., Doctor B.P. Cholinesterase and carboxylesterase as scavengers for organophosphorous agents. Massoulie J., Bacou F., Barnard E., Chatonnet A., Doctor B.P., Quinn D.M. Cholinesterases. Structure, function, mechanism, genetics, and cell biology:1991;206-209 American Chemical Society, Washington, DC.
17. Sidell F.R. Soman and sarin. Clinical manifestations and treatment of accidental poisoning by organophosphates Clin. Toxicol. 7:1974;1-17.
18. Raveh L., Ashani Y., Levy D., De La Hoz D., Wolfe A., Doctor B.P. Acetylcholinesterase prophylaxis against organophosphate toxicity. Biochem. Pharmacol. 38:1989;529-534.
19. Raveh L., Grauer E., Grunwald J., Cohen E., Ashani Y. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase. Toxicol. Appl. Pharmacol. 145:1997;43-53.
20. Raveh L., Grunwald J., Marcus D., Papier Y., Cohen E., Ashani Y. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. Biochem. Pharmacol. 45:1993;2465-2474.
21. Wickelgren W.A., Norman D.A. Strength models and serial position in short-term recognition memory. J. Math. Psychol. 3:1966;316-347.
22. Wolfe A.D., Blick D.W., Murphy M.R., Miller S.A., Gentry M.K., Hartgraves S.L., Doctor B.P. Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity. Toxicol. Appl. Pharmacol. 117:1992;189-193.
23. Wolfe A.D., Rush R.S., Doctor B.P., Koplovitz I., Jones D. Acetylcholinesterase prophylaxis against organophosphate toxicity. Fund. Appl. Toxicol. 9:1987;266-270.
24. Wright A.A., Santiago H.C., Sands S.F., Kendrick D.F., Cook R.G. Memory processing of serial lists by pigeons, monkeys, and people. Science. 229:1985;287-289.